180 related articles for article (PubMed ID: 15777220)
1. Activation of p53 by specific agents in potential cancer therapy.
Ho JW; Song JZ; Leung YK
Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):131-5. PubMed ID: 15777220
[TBL] [Abstract][Full Text] [Related]
2. PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein.
Liang Y; Besch-Williford C; Hyder SM
Int J Oncol; 2009 Nov; 35(5):1015-23. PubMed ID: 19787255
[TBL] [Abstract][Full Text] [Related]
3. Restoring p53-dependent tumor suppression.
Wang W; Rastinejad F; El-Deiry WS
Cancer Biol Ther; 2003; 2(4 Suppl 1):S55-63. PubMed ID: 14508081
[TBL] [Abstract][Full Text] [Related]
4. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Baptiste N; Friedlander P; Chen X; Prives C
Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
[TBL] [Abstract][Full Text] [Related]
5. Restoration of wild-type p53 function in human tumors: strategies for efficient cancer therapy.
Wiman KG
Adv Cancer Res; 2007; 97():321-38. PubMed ID: 17419952
[TBL] [Abstract][Full Text] [Related]
6. Restoration of wild-type p53 function in human cancer: relevance for tumor therapy.
Bossi G; Sacchi A
Head Neck; 2007 Mar; 29(3):272-84. PubMed ID: 17230559
[TBL] [Abstract][Full Text] [Related]
7. Wild type p53 function in p53
Sundar D; Yu Y; Katiyar SP; Putri JF; Dhanjal JK; Wang J; Sari AN; Kolettas E; Kaul SC; Wadhwa R
J Exp Clin Cancer Res; 2019 Feb; 38(1):103. PubMed ID: 30808373
[TBL] [Abstract][Full Text] [Related]
8. Classic and novel roles of p53: prospects for anticancer therapy.
Fuster JJ; Sanz-González SM; Moll UM; Andrés V
Trends Mol Med; 2007 May; 13(5):192-9. PubMed ID: 17383232
[TBL] [Abstract][Full Text] [Related]
9. An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells.
Chang GC; Yu CT; Tsai CH; Tsai JR; Chen JC; Wu CC; Wu WJ; Hsu SL
Eur J Pharmacol; 2008 Dec; 600(1-3):37-44. PubMed ID: 18973751
[TBL] [Abstract][Full Text] [Related]
10. Advances in adenovirus-mediated p53 cancer gene therapy.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
[TBL] [Abstract][Full Text] [Related]
11. Restoration of the tumor-suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells.
Jiang D; Wang L; Zhao T; Zhang Z; Zhang R; Jin J; Cai Y; Wang F
Oncol Rep; 2017 Jan; 37(1):594-600. PubMed ID: 27878254
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of mutant p53: a new strategy for cancer therapy.
Selivanova G; Kawasaki T; Ryabchenko L; Wiman KG
Semin Cancer Biol; 1998; 8(5):369-78. PubMed ID: 10101802
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic targeting of the p53 tumor suppressor gene.
Beaudry GA; Bertelsen AH; Sherman MI
Curr Opin Biotechnol; 1996 Dec; 7(6):592-600. PubMed ID: 8939636
[TBL] [Abstract][Full Text] [Related]
14. Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.
Newton HB
Expert Rev Anticancer Ther; 2005 Feb; 5(1):177-91. PubMed ID: 15757449
[TBL] [Abstract][Full Text] [Related]
15. A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer.
Milner J
Proc Biol Sci; 1991 Aug; 245(1313):139-45. PubMed ID: 1682937
[TBL] [Abstract][Full Text] [Related]
16. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
Wu GS; Ding Z
Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
[TBL] [Abstract][Full Text] [Related]
17. The role of p53 and pRB in apoptosis and cancer.
Hickman ES; Moroni MC; Helin K
Curr Opin Genet Dev; 2002 Feb; 12(1):60-6. PubMed ID: 11790556
[TBL] [Abstract][Full Text] [Related]
18. Rescue of mutant p53 transcription function by ellipticine.
Peng Y; Li C; Chen L; Sebti S; Chen J
Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704
[TBL] [Abstract][Full Text] [Related]
19. [Role of the p53 and bcl-2 genes in apoptosis and drug resistance of tumors].
Luk'ianova NIu; Kulik GI; Chehun VF
Vopr Onkol; 2000; 46(2):121-8. PubMed ID: 10853407
[No Abstract] [Full Text] [Related]
20. Wild-type p53 protein potentiates cytotoxicity of therapeutic agents in human colon cancer cells.
Yang B; Eshleman JR; Berger NA; Markowitz SD
Clin Cancer Res; 1996 Oct; 2(10):1649-57. PubMed ID: 9816112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
